Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
LINC01524 (Long intergenic non-protein coding RNA 1524) is a human long non-coding RNA (lncRNA), part of a class of transcripts longer than 200 nucleotides that are not translated into protein. It belongs to the "long intergenic non-coding RNA" category, indicating it is transcribed from an intergenic region (between protein-coding genes) and does not encode a functional protein. As of September 2025, there is no published literature describing any specific biological function, disease association, or potential as a therapeutic target for LINC01524. No evidence currently supports its role as a validated drug target, biomarker, or participant in well-known signaling pathways, nor are there any drugs reported to interact with it. There is no indication that it is relevant as a therapeutic target, nor is it recognized for involvement in disease mechanisms. Additionally, available scientific resources may conflate "LINC01524" with similar lncRNA names, so care must be taken to distinguish it from other lncRNAs (e.g., LINC00324, which is implicated in cancer), but the information here specifically applies only to LINC01524. **Note:** Due to the lack of research and functional annotation, LINC01524 is not recognized as a therapeutic target, no drug interactions or mechanisms of action are known, and it may be considered *not sufficiently characterized* for structured therapeutic targeting at this time.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1524 (LINC01524).